Coronado Biosciences slips on Oppenheimer downgrade

|By:, SA News Editor

Coronado Biosciences (CNDO) falls 4.8% premarket.

Behind the move looks to be Oppenheimer, where analysts have cut the shares to Perform from Outperform.

$2.50 price target removed.